Table 2 Baseline drug administration
Therapy | |
|---|---|
Oral anti-diabetic drugs, n (%) | 69 (73) |
 Metformin, n (%) | 35 (37) |
 Sulfonylureas, n (%) | 25 (27) |
 Thiazolidinediones, n (%) | 10 (11) |
 Glinides, n (%) | 3 (3) |
 DPP-4 inhibitors, n (%) | 46 (49) |
 α-glucosidase inhibitors, n (%) | 5 (5) |
 SGLT2 inhibitors, n (%) | 11 (12) |
 GLP-1 receptor agonists, n (%) | 3 (3) |
 Insulin, n (%) | 12 (13) |
Anti-hypertensive agents, n (%) | 45 (48) |
 RAAS inhibitors, n (%) | 34 (36) |
 Calcium-channel blockers, n (%) | 32 (34) |
 Thiazides, n (%) | 5 (5) |
 Beta-blockers, n (%) | 5 (5) |
Lipid-lowering agents, n (%) | 32 (34) |
 Statins, n (%) | 28 (30) |